Global General Anaesthesia Drugs Market Research Report 2022
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global General Anaesthesia Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Propofol
1.2.3 Sevoflurane
1.2.4 Isoflurane
1.2.5 Dexmedetomidine
1.2.6 Desflurane
1.2.7 Remifentanil
1.2.8 Midazolam
1.2.9 Others
1.3 Market by Application
1.3.1 Global General Anaesthesia Drugs Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global General Anaesthesia Drugs Market Perspective (2017-2028)
2.2 General Anaesthesia Drugs Growth Trends by Region
2.2.1 General Anaesthesia Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 General Anaesthesia Drugs Historic Market Size by Region (2017-2022)
2.2.3 General Anaesthesia Drugs Forecasted Market Size by Region (2023-2028)
2.3 General Anaesthesia Drugs Market Dynamics
2.3.1 General Anaesthesia Drugs Industry Trends
2.3.2 General Anaesthesia Drugs Market Drivers
2.3.3 General Anaesthesia Drugs Market Challenges
2.3.4 General Anaesthesia Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top General Anaesthesia Drugs Players by Revenue
3.1.1 Global Top General Anaesthesia Drugs Players by Revenue (2017-2022)
3.1.2 Global General Anaesthesia Drugs Revenue Market Share by Players (2017-2022)
3.2 Global General Anaesthesia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by General Anaesthesia Drugs Revenue
3.4 Global General Anaesthesia Drugs Market Concentration Ratio
3.4.1 Global General Anaesthesia Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by General Anaesthesia Drugs Revenue in 2021
3.5 General Anaesthesia Drugs Key Players Head office and Area Served
3.6 Key Players General Anaesthesia Drugs Product Solution and Service
3.7 Date of Enter into General Anaesthesia Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 General Anaesthesia Drugs Breakdown Data by Type
4.1 Global General Anaesthesia Drugs Historic Market Size by Type (2017-2022)
4.2 Global General Anaesthesia Drugs Forecasted Market Size by Type (2023-2028)
5 General Anaesthesia Drugs Breakdown Data by Application
5.1 Global General Anaesthesia Drugs Historic Market Size by Application (2017-2022)
5.2 Global General Anaesthesia Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America General Anaesthesia Drugs Market Size (2017-2028)
6.2 North America General Anaesthesia Drugs Market Size by Country (2017-2022)
6.3 North America General Anaesthesia Drugs Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe General Anaesthesia Drugs Market Size (2017-2028)
7.2 Europe General Anaesthesia Drugs Market Size by Country (2017-2022)
7.3 Europe General Anaesthesia Drugs Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific General Anaesthesia Drugs Market Size (2017-2028)
8.2 Asia-Pacific General Anaesthesia Drugs Market Size by Country (2017-2022)
8.3 Asia-Pacific General Anaesthesia Drugs Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America General Anaesthesia Drugs Market Size (2017-2028)
9.2 Latin America General Anaesthesia Drugs Market Size by Country (2017-2022)
9.3 Latin America General Anaesthesia Drugs Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa General Anaesthesia Drugs Market Size (2017-2028)
10.2 Middle East & Africa General Anaesthesia Drugs Market Size by Country (2017-2022)
10.3 Middle East & Africa General Anaesthesia Drugs Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Baxter International
11.1.1 Baxter International Company Detail
11.1.2 Baxter International Business Overview
11.1.3 Baxter International General Anaesthesia Drugs Introduction
11.1.4 Baxter International Revenue in General Anaesthesia Drugs Business (2017-2022)
11.1.5 Baxter International Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca General Anaesthesia Drugs Introduction
11.2.4 AstraZeneca Revenue in General Anaesthesia Drugs Business (2017-2022)
11.2.5 AstraZeneca Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Detail
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories General Anaesthesia Drugs Introduction
11.3.4 Abbott Laboratories Revenue in General Anaesthesia Drugs Business (2017-2022)
11.3.5 Abbott Laboratories Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche General Anaesthesia Drugs Introduction
11.4.4 Roche Revenue in General Anaesthesia Drugs Business (2017-2022)
11.4.5 Roche Recent Development
11.5 Fresenius
11.5.1 Fresenius Company Detail
11.5.2 Fresenius Business Overview
11.5.3 Fresenius General Anaesthesia Drugs Introduction
11.5.4 Fresenius Revenue in General Anaesthesia Drugs Business (2017-2022)
11.5.5 Fresenius Recent Development
11.6 Mylan
11.6.1 Mylan Company Detail
11.6.2 Mylan Business Overview
11.6.3 Mylan General Anaesthesia Drugs Introduction
11.6.4 Mylan Revenue in General Anaesthesia Drugs Business (2017-2022)
11.6.5 Mylan Recent Development
11.7 Eisai
11.7.1 Eisai Company Detail
11.7.2 Eisai Business Overview
11.7.3 Eisai General Anaesthesia Drugs Introduction
11.7.4 Eisai Revenue in General Anaesthesia Drugs Business (2017-2022)
11.7.5 Eisai Recent Development
11.8 Hospira
11.8.1 Hospira Company Detail
11.8.2 Hospira Business Overview
11.8.3 Hospira General Anaesthesia Drugs Introduction
11.8.4 Hospira Revenue in General Anaesthesia Drugs Business (2017-2022)
11.8.5 Hospira Recent Development
11.9 Hikma Pharmaceuticals
11.9.1 Hikma Pharmaceuticals Company Detail
11.9.2 Hikma Pharmaceuticals Business Overview
11.9.3 Hikma Pharmaceuticals General Anaesthesia Drugs Introduction
11.9.4 Hikma Pharmaceuticals Revenue in General Anaesthesia Drugs Business (2017-2022)
11.9.5 Hikma Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global General Anaesthesia Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Propofol
Table 3. Key Players of Sevoflurane
Table 4. Key Players of Isoflurane
Table 5. Key Players of Dexmedetomidine
Table 6. Key Players of Desflurane
Table 7. Key Players of Remifentanil
Table 8. Key Players of Midazolam
Table 9. Key Players of Others
Table 10. Global General Anaesthesia Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global General Anaesthesia Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 12. Global General Anaesthesia Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 13. Global General Anaesthesia Drugs Market Share by Region (2017-2022)
Table 14. Global General Anaesthesia Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 15. Global General Anaesthesia Drugs Market Share by Region (2023-2028)
Table 16. General Anaesthesia Drugs Market Trends
Table 17. General Anaesthesia Drugs Market Drivers
Table 18. General Anaesthesia Drugs Market Challenges
Table 19. General Anaesthesia Drugs Market Restraints
Table 20. Global General Anaesthesia Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 21. Global General Anaesthesia Drugs Market Share by Players (2017-2022)
Table 22. Global Top General Anaesthesia Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anaesthesia Drugs as of 2021)
Table 23. Ranking of Global Top General Anaesthesia Drugs Companies by Revenue (US$ Million) in 2021
Table 24. Global 5 Largest Players Market Share by General Anaesthesia Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players General Anaesthesia Drugs Product Solution and Service
Table 27. Date of Enter into General Anaesthesia Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global General Anaesthesia Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 30. Global General Anaesthesia Drugs Revenue Market Share by Type (2017-2022)
Table 31. Global General Anaesthesia Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 32. Global General Anaesthesia Drugs Revenue Market Share by Type (2023-2028)
Table 33. Global General Anaesthesia Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 34. Global General Anaesthesia Drugs Revenue Market Share by Application (2017-2022)
Table 35. Global General Anaesthesia Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 36. Global General Anaesthesia Drugs Revenue Market Share by Application (2023-2028)
Table 37. North America General Anaesthesia Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America General Anaesthesia Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe General Anaesthesia Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 40. Europe General Anaesthesia Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 41. Asia-Pacific General Anaesthesia Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 42. Asia-Pacific General Anaesthesia Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 43. Latin America General Anaesthesia Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 44. Latin America General Anaesthesia Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 45. Middle East & Africa General Anaesthesia Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 46. Middle East & Africa General Anaesthesia Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 47. Baxter International Company Detail
Table 48. Baxter International Business Overview
Table 49. Baxter International General Anaesthesia Drugs Product
Table 50. Baxter International Revenue in General Anaesthesia Drugs Business (2017-2022) & (US$ Million)
Table 51. Baxter International Recent Development
Table 52. AstraZeneca Company Detail
Table 53. AstraZeneca Business Overview
Table 54. AstraZeneca General Anaesthesia Drugs Product
Table 55. AstraZeneca Revenue in General Anaesthesia Drugs Business (2017-2022) & (US$ Million)
Table 56. AstraZeneca Recent Development
Table 57. Abbott Laboratories Company Detail
Table 58. Abbott Laboratories Business Overview
Table 59. Abbott Laboratories General Anaesthesia Drugs Product
Table 60. Abbott Laboratories Revenue in General Anaesthesia Drugs Business (2017-2022) & (US$ Million)
Table 61. Abbott Laboratories Recent Development
Table 62. Roche Company Detail
Table 63. Roche Business Overview
Table 64. Roche General Anaesthesia Drugs Product
Table 65. Roche Revenue in General Anaesthesia Drugs Business (2017-2022) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Fresenius Company Detail
Table 68. Fresenius Business Overview
Table 69. Fresenius General Anaesthesia Drugs Product
Table 70. Fresenius Revenue in General Anaesthesia Drugs Business (2017-2022) & (US$ Million)
Table 71. Fresenius Recent Development
Table 72. Mylan Company Detail
Table 73. Mylan Business Overview
Table 74. Mylan General Anaesthesia Drugs Product
Table 75. Mylan Revenue in General Anaesthesia Drugs Business (2017-2022) & (US$ Million)
Table 76. Mylan Recent Development
Table 77. Eisai Company Detail
Table 78. Eisai Business Overview
Table 79. Eisai General Anaesthesia Drugs Product
Table 80. Eisai Revenue in General Anaesthesia Drugs Business (2017-2022) & (US$ Million)
Table 81. Eisai Recent Development
Table 82. Hospira Company Detail
Table 83. Hospira Business Overview
Table 84. Hospira General Anaesthesia Drugs Product
Table 85. Hospira Revenue in General Anaesthesia Drugs Business (2017-2022) & (US$ Million)
Table 86. Hospira Recent Development
Table 87. Hikma Pharmaceuticals Company Detail
Table 88. Hikma Pharmaceuticals Business Overview
Table 89. Hikma Pharmaceuticals General Anaesthesia Drugs Product
Table 90. Hikma Pharmaceuticals Revenue in General Anaesthesia Drugs Business (2017-2022) & (US$ Million)
Table 91. Hikma Pharmaceuticals Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of FiguresFigure 1. Global General Anaesthesia Drugs Market Share by Type: 2021 VS 2028
Figure 2. Propofol Features
Figure 3. Sevoflurane Features
Figure 4. Isoflurane Features
Figure 5. Dexmedetomidine Features
Figure 6. Desflurane Features
Figure 7. Remifentanil Features
Figure 8. Midazolam Features
Figure 9. Others Features
Figure 10. Global General Anaesthesia Drugs Market Share by Application in 2021 & 2028
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Others Case Studies
Figure 14. General Anaesthesia Drugs Report Years Considered
Figure 15. Global General Anaesthesia Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 16. Global General Anaesthesia Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global General Anaesthesia Drugs Market Share by Region: 2021 VS 2028
Figure 18. Global General Anaesthesia Drugs Market Share by Players in 2021
Figure 19. Global Top General Anaesthesia Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anaesthesia Drugs as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by General Anaesthesia Drugs Revenue in 2021
Figure 21. North America General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. North America General Anaesthesia Drugs Market Share by Country (2017-2028)
Figure 23. United States General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe General Anaesthesia Drugs Market Share by Country (2017-2028)
Figure 27. Germany General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific General Anaesthesia Drugs Market Share by Region (2017-2028)
Figure 35. China General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Latin America General Anaesthesia Drugs Market Share by Country (2017-2028)
Figure 43. Mexico General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Brazil General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa General Anaesthesia Drugs Market Share by Country (2017-2028)
Figure 47. Turkey General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Saudi Arabia General Anaesthesia Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Baxter International Revenue Growth Rate in General Anaesthesia Drugs Business (2017-2022)
Figure 50. AstraZeneca Revenue Growth Rate in General Anaesthesia Drugs Business (2017-2022)
Figure 51. Abbott Laboratories Revenue Growth Rate in General Anaesthesia Drugs Business (2017-2022)
Figure 52. Roche Revenue Growth Rate in General Anaesthesia Drugs Business (2017-2022)
Figure 53. Fresenius Revenue Growth Rate in General Anaesthesia Drugs Business (2017-2022)
Figure 54. Mylan Revenue Growth Rate in General Anaesthesia Drugs Business (2017-2022)
Figure 55. Eisai Revenue Growth Rate in General Anaesthesia Drugs Business (2017-2022)
Figure 56. Hospira Revenue Growth Rate in General Anaesthesia Drugs Business (2017-2022)
Figure 57. Hikma Pharmaceuticals Revenue Growth Rate in General Anaesthesia Drugs Business (2017-2022)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed